CDC ADDS CERVICAL VACCINE TO VFC PROGRAM

DECEMBER 01, 2006

The Centers for Disease Control and Prevention (CDC) has added Gardasil (Merck & Co) to its Vaccines for Children (VFC) contract. The vaccine, approved by the FDA in June 2006, protects against 4 strains of the human papillomavirus.

The decision will make the vaccine available for girls and women aged 9 to 18 years who are eligible for the program. The vaccine was approved for females aged 9 to 26. The VFC program provides access to vaccines for children through age 18 who are eligible for Medicaid or are uninsured, underinsured, or Native American, according to the drugmaker.

"Inclusion of Gardasil in the VFC program, coupled with private insurance coverage and Merck's Vaccine Patient Assistance Program, [is an] important means to facilitate broad and equitable access to Gardasil," said Mark Feinberg, MD, PhD, Merck Vaccine Division vice president for policy, public health and medical affairs.




SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.